Soleo Health to provide Cuvitru
By HME News Staff
Updated 11:54 AM CDT, Thu August 4, 2022
FRISCO, Texas – Soleo Health has been chosen as one of a select few specialty pharmacies to provide Cuvitru, manufactured by Takeda Pharmaceutical Company, to patients nationwide. “Access to Cuvitru rounds out Soleo Health’s comprehensive immunoglobulin (Ig) therapy offering,” said Drew Walk, Soleo Health’s CEO. “With this addition, Soleo Health now offers all FDA-approved Ig therapies available in the marketplace today. We continue to cater to the needs of our patients and prescribers by broadening our therapeutic portfolio and providing exceptional care.” Cuvitru replaces antibodies not working correctly or are missing from one’s body to help protect it against infection. Cuvitru is for treating primary immunodeficiency in adults and children two years of age and older.
Comments